HYZAAR Side Effects

7023524-X | Presyncope
on Sep 27, 2010 Female patient from DENMARK , 71 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: presyncope. Hyzaar dosage: . Patient was hospitalized.

7008734-X | Primary Hyperaldosteronism
Patient was taking Hyzaar (View Usage). Patient had the following side effects: primary hyperaldosteronism on Sep 14, 2010 from JAPAN Additional patient health information: Male patient , 82 years of age, was diagnosed with hypertension and. Hyzaar dosage: 1 Tab/daily Po. During the same period patient was treated with CONIEL (View Coniel Review and Coniel Label ), GLIMICRON (View Glimicron Review and Glimicron Label ), PEPCID RPD (View Pepcid Rpd Review and Pepcid Rpd Label ).

7007823-3 | Skin Ulcer
Adverse event was reported on Sep 16, 2010 by a Male patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: FRANCE , 61 years of age, After Hyzaar was administered, patient had the following side effects: skin ulcer. During the same period patient was treated with ADANCOR (View Adancor Review and Adancor Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), PLAVIX (View Plavix Review and Plavix Label ), ELISOR (View Elisor Review and Elisor Label ). Patient was hospitalized.

7007593-9 | Hypoaesthesia Oral
on Sep 16, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia oral. Hyzaar dosage: 1 Dose/daily, Po. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ).


7005738-8 | Normal Pressure Hydrocephalus
on Sep 10, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with Hyzaar (View Usage). Patient had the following side effects: normal pressure hydrocephalus. Hyzaar dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

7001875-2 |
Patient was taking Hyzaar (View Usage). on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, . Hyzaar dosage: . During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6978948-3 | Restless Legs Syndrome
Adverse event was reported on Sep 08, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED KINGDOM , 75 years of age, Patient experienced the following unwanted or unexpected effects: restless legs syndrome. During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BECLOMETHASONE DIPROPIONATE AND FORMOTEROL FUMARATE (View Beclomethasone Dipropionate And Formoterol Fumarate Review and Beclomethasone Dipropionate And Formoterol Fumarate Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ACETAMINOPHEN AND BUCLIZINE HYDROCHLORIDE AND CODEINE PHOSPHATE (View Acetaminophen And Buclizine Hydrochloride And Codeine Phosphate Review and Acetaminophen And Buclizine Hydrochloride And Codeine Phosphate Label ), QUININE SULFATE (View Quinine Sulfate Review and Quinine Sulfate Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ).

6973441-6 | Anaphylactic Shock, Blood Pressure Decreased, Urticaria, Vomiting
on Sep 01, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with hypertension, hepatitis b (What is hepatitis b?), blood cholesterol increased and was treated with Hyzaar (View Usage). Patient had the following side effects: anaphylactic shock, blood pressure decreased, urticaria, vomiting. Hyzaar dosage: . During the same period patient was treated with PROHEPARUM (View Proheparum Review and Proheparum Label ), GASLON (Morning) (View Gaslon Review and Gaslon Label ), FLUVASTATIN (Evening) (View Fluvastatin Review and Fluvastatin Label ), DEPAS (Evening In Morning) (View Depas Review and Depas Label ), MYSLEE (Before Retiring) (View Myslee Review and Myslee Label ), GOREI SAN (View Gorei-san Review and Gorei-san Label ), MENIACE (View Meniace Review and Meniace Label ), HYPEN (View Hypen Review and Hypen Label ). Patient was hospitalized.

6965763-X | Hypokalaemia, Myopathy, Pseudoaldosteronism
on Jun 30, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with hypertension, arthralgia, hyperlipidaemia and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: hypokalaemia, myopathy, pseudoaldosteronism. Hyzaar dosage: . During the same period patient was treated with SHAKUYAKU KANZO TO (View Shakuyaku-kanzo-to Review and Shakuyaku-kanzo-to Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ). Patient was hospitalized.

6963261-0 | Febrile Neutropenia, Hepatic Function Abnormal, Leukopenia
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, hepatic function abnormal, leukopenia on Aug 25, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, weighting 97.00 lb, was diagnosed with hypertension, hyperuricaemia, osteoporosis (What is osteoporosis?), acidosis, prophylaxis and. Hyzaar dosage: . During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), ALFAROL (View Alfarol Review and Alfarol Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), MAXIPIME (View Maxipime Review and Maxipime Label ). Patient was hospitalized.

6961779-8 | Caesarean Section, Hypertension, Oligohydramnios, Premature Labour, Renal Failure
Adverse event was reported on Aug 23, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension, renal failure chronic and. Location: JAPAN , 36 years of age, weighting 134.5 lb, Patient had the following side effects: caesarean section, hypertension, oligohydramnios, premature labour, renal failure.

6961046-2 | Caesarean Section, Congenital Hepatobiliary Anomaly, Oligohydramnios, Pulmonary Hypoplasia, Renal Failure
on Aug 23, 2010 Female patient from JAPAN , weighting 2.20 lb, was diagnosed with hypertension, renal failure chronic and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: caesarean section, congenital hepatobiliary anomaly, oligohydramnios, pulmonary hypoplasia, renal failure. Hyzaar dosage: .

6959033-3 | Coronary Artery Occlusion, Coronary Artery Stenosis, Ejection Fraction Decreased, Hypokalaemia, Left Ventricular Dysfunction, Myocardial Infarction
on Aug 16, 2010 Female patient from UNITED STATES , 53 years of age, weighting 189.0 lb, was diagnosed with non-small cell lung cancer and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery occlusion, coronary artery stenosis, ejection fraction decreased, hypokalaemia, left ventricular dysfunction, myocardial infarction. Hyzaar dosage: 100/25 Mg/daily/po. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg/daily/po) (View Sunitinib Malate Review and Sunitinib Malate Label ), TOPROL XL (12.5 Mg/daily) (View Toprol-xl Review and Toprol-xl Label ).

6939048-1 | Anaphylactic Shock, Urticaria
Patient was taking Hyzaar (View Usage). Patient had the following side effects: anaphylactic shock, urticaria on Aug 18, 2010 from JAPAN Additional patient health information: Female patient , 77 years of age, was diagnosed with hypertension and. Hyzaar dosage: . During the same period patient was treated with PROHEPARUM (View Proheparum Review and Proheparum Label ), GASLON (Morning) (View Gaslon Review and Gaslon Label ), FLUVASTATIN (Evening) (View Fluvastatin Review and Fluvastatin Label ), DEPAS (Evening In Morning) (View Depas Review and Depas Label ), MYSLEE (Before Retiring) (View Myslee Review and Myslee Label ), GOREI SAN (View Gorei-san Review and Gorei-san Label ), MENIACE (View Meniace Review and Meniace Label ), HYPEN (View Hypen Review and Hypen Label ). Patient was hospitalized.

6934101-0 | Condition Aggravated, Cough
Adverse event was reported on Aug 16, 2010 by a Male patient taking Hyzaar (View Usage) (Dosage: ) . Location: FRANCE , 68 years of age, After Hyzaar was administered, patient had the following side effects: condition aggravated, cough. During the same period patient was treated with ALISKIREN FUMARATE AND HYDROCHLOROTHIAZIDE (View Aliskiren Fumarate And Hydrochlorothiazide Review and Aliskiren Fumarate And Hydrochlorothiazide Label ), TROSPIUM CHLORIDE (View Trospium Chloride Review and Trospium Chloride Label ), TRIMETAZIDINE HYDROCHLORIDE (View Trimetazidine Hydrochloride Review and Trimetazidine Hydrochloride Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6934099-5 | Hyponatraemia
on Aug 10, 2010 Male patient from JAPAN , 81 years of age, was diagnosed with hypertension, hypertrophic cardiomyopathy, percutaneous coronary intervention, angina pectoris, dyslipidaemia and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Hyzaar dosage: . During the same period patient was treated with MAINTATE (View Maintate Review and Maintate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIGMART (View Sigmart Review and Sigmart Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6925587-6 | Arthritis, Cervicobrachial Syndrome, Feeling Abnormal, Muscle Atrophy, Myalgia, Nerve Compression, Oedema Peripheral, Spinal Column Stenosis, Ulnar Nerve Palsy
on Aug 12, 2010 Male patient from FRANCE , 61 years of age, was diagnosed with hypertension, hiv infection (What is hiv infection?), prophylaxis and was treated with Hyzaar (View Usage). Patient had the following side effects: arthritis (What is arthritis?), cervicobrachial syndrome, feeling abnormal, muscle atrophy, myalgia, nerve compression, oedema peripheral, spinal column stenosis, ulnar nerve palsy. Hyzaar dosage: . During the same period patient was treated with EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), COZAAR (View Cozaar Review and Cozaar Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), ATHYMIL (View Athymil Review and Athymil Label ). Patient was hospitalized.

6914637-9 | Hypertension, Oligohydramnios, Premature Labour, Renal Failure
Patient was taking Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: hypertension, oligohydramnios, premature labour, renal failure on Jul 30, 2010 from JAPAN Additional patient health information: Female patient , 36 years of age, weighting 134.5 lb, was diagnosed with hypertension, renal failure chronic and. Hyzaar dosage: .

6912350-5 | Pulmonary Hypoplasia, Urinary Tract Malformation
Adverse event was reported on Jul 30, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension, renal failure chronic and. Location: JAPAN , weighting 2.20 lb, Patient experienced the following unwanted or unexpected effects: pulmonary hypoplasia, urinary tract malformation.

6906163-8 | Anaphylactic Shock, Blood Pressure Decreased, Urticaria, Vomiting
on Jul 28, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: anaphylactic shock, blood pressure decreased, urticaria, vomiting. Hyzaar dosage: . During the same period patient was treated with PROHEPARUM (View Proheparum Review and Proheparum Label ), GASLON (Morning) (View Gaslon Review and Gaslon Label ), FLUVASTATIN (Evening) (View Fluvastatin Review and Fluvastatin Label ), DEPAS (Evening In Morning) (View Depas Review and Depas Label ), MYSLEE (Before Retiring) (View Myslee Review and Myslee Label ), GOREI SAN (View Gorei-san Review and Gorei-san Label ), MENIACE (View Meniace Review and Meniace Label ), HYPEN (View Hypen Review and Hypen Label ). Patient was hospitalized.

6878462-X | Hepatotoxicity, Renal Failure Acute
on Jul 23, 2010 Male patient from UNITED STATES , 83 years of age, was diagnosed with hypertension, dementia alzheimer's type, transient ischaemic attack and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: hepatotoxicity, renal failure acute. Hyzaar dosage: . During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), ARICEPT (View Aricept Review and Aricept Label ), AGGRENOX (View Aggrenox Review and Aggrenox Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

6876048-4 | Acute Myocardial Infarction
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction on Jul 16, 2010 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with hypertension and. Hyzaar dosage: . During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), BUSPIRONE HYDROCHLORIDE (View Buspirone Hydrochloride Review and Buspirone Hydrochloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PLAVIX (View Plavix Review and Plavix Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6874951-2 | Blood Pressure Decreased
Adverse event was reported on May 12, 2009 by a Male patient taking Hyzaar (View Usage) (Dosage: Po) was diagnosed with hypertension, cataplexy, narcolepsy, memory impairment and. Location: UNITED STATES , 39 years of age, Patient had the following side effects: blood pressure decreased. During the same period patient was treated with XYREM (3 Gm/po ; 4.5 Gm/bid/po) (View Xyrem Review and Xyrem Label ), ADDERALL TABLETS UNK (View Adderall Tablets Unk Review and Adderall Tablets Unk Label ), COZAAR (Po) (View Cozaar Review and Cozaar Label ).

6874949-4 | Blood Pressure Decreased
on Jun 09, 2009 Male patient from UNITED STATES , 39 years of age, was diagnosed with hypertension, cataplexy, narcolepsy, memory impairment and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: blood pressure decreased. Hyzaar dosage: Po. During the same period patient was treated with XYREM (3 Gm/po ; 4.g Gm/bid/po) (View Xyrem Review and Xyrem Label ), COZAAR (Po) (View Cozaar Review and Cozaar Label ), ADDERALL TABLETS UNK (View Adderall Tablets Unk Review and Adderall Tablets Unk Label ).

6874946-9 | Blood Potassium Decreased, Blood Sodium Decreased, Electrolyte Imbalance
on Jul 01, 2009 Female patient from UNITED STATES , 73 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, blood sodium decreased, electrolyte imbalance. Hyzaar dosage: 100-25 Mg/daily/po. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LOVAZA (View Lovaza Review and Lovaza Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6874942-1 | Cerebrovascular Accident, Flushing, Headache
Patient was taking Hyzaar (View Usage). Patient had the following side effects: cerebrovascular accident, flushing, headache (What is headache?) on Nov 24, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with hypertension and. Hyzaar dosage: Po. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6874940-8 | Malaise, Muscle Spasms
Adverse event was reported on Apr 28, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: 100-25 Mg/po) . Location: UNITED STATES , 61 years of age, After Hyzaar was administered, patient had the following side effects: malaise, muscle spasms. During the same period patient was treated with LIPITOR (20 Mg/po) (View Lipitor Review and Lipitor Label ), PREMARIN (0.3 Mg) (View Premarin Review and Premarin Label ).

6874937-8 | Palpitations, Rash Maculo-papular
on May 15, 2009 Female patient from UNITED STATES , 54 years of age, weighting 238.0 lb, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: palpitations, rash maculo-papular. Hyzaar dosage: 100 Mg/daily/po. During the same period patient was treated with BENICAR (View Benicar Review and Benicar Label ). Patient was hospitalized.

6867325-1 | Blood Pressure Increased, Hospitalisation
on Jul 20, 2010 Male patient from UNITED STATES , 51 years of age, was treated with Hyzaar (View Usage). Patient had the following side effects: blood pressure increased, hospitalisation. Hyzaar dosage: . Patient was hospitalized.

6867320-2 | Shock
Patient was taking Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: shock on Jul 15, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, weighting 163.1 lb, was diagnosed with hypertension and. Hyzaar dosage: . During the same period patient was treated with ATELEC (View Atelec Review and Atelec Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

6867316-0 | Blood Creatinine Increased, Blood Urea Increased, Rhabdomyolysis
Adverse event was reported on Jul 12, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) . Location: JAPAN , 88 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, rhabdomyolysis. During the same period patient was treated with BEZATOL (View Bezatol Review and Bezatol Label ), ATELEC (View Atelec Review and Atelec Label ), VESICARE (View Vesicare Review and Vesicare Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ETOLAC (ETODOLAC) (View Etolac (etodolac) Review and Etolac (etodolac) Label ), PLATIBIT (View Platibit Review and Platibit Label ), VANARL N (View Vanarl N Review and Vanarl N Label ). Patient was hospitalized.

6864239-8 | Leukoderma
on Jul 14, 2010 Female patient from JAPAN , 80 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: leukoderma. Hyzaar dosage: . During the same period patient was treated with NORVASC (Divided Dose Frequency U) (View Norvasc Review and Norvasc Label ), CRESTOR (Divided Dose Frequency U) (View Crestor Review and Crestor Label ), ACTONEL (Divided Dose Frequency U) (View Actonel Review and Actonel Label ), LOXONIN (View Loxonin Review and Loxonin Label ), OMEPRAL (View Omepral Review and Omepral Label ).

6860806-6 | Anaphylactic Shock, Urticaria
on Jul 13, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: anaphylactic shock, urticaria. Hyzaar dosage: . During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), PROHEPARUM (View Proheparum Review and Proheparum Label ), GASLON (View Gaslon Review and Gaslon Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), DEPAS (View Depas Review and Depas Label ), MYSLEE (View Myslee Review and Myslee Label ), GOREI SAN (View Gorei-san Review and Gorei-san Label ), MENIACE (View Meniace Review and Meniace Label ). Patient was hospitalized.

6827067-5 | Arrhythmia
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?) on Jul 01, 2010 from JAPAN Additional patient health information: Female patient , 82 years of age, weighting 72.75 lb, was diagnosed with hypertension and. Hyzaar dosage: . During the same period patient was treated with CYCLOSERINE (View Cycloserine Review and Cycloserine Label ), JUVELA (View Juvela Review and Juvela Label ), NORVASC (View Norvasc Review and Norvasc Label ), MICARDIS (View Micardis Review and Micardis Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ).

6827038-9 | Hypokalaemia, Myopathy, Pseudoaldosteronism
Adverse event was reported on Jun 30, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension, arthralgia, hyperlipidaemia and. Location: JAPAN , 74 years of age, Patient had the following side effects: hypokalaemia, myopathy, pseudoaldosteronism. During the same period patient was treated with SHAKUYAKU KANZO TO (View Shakuyaku-kanzo-to Review and Shakuyaku-kanzo-to Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ). Patient was hospitalized.

6817863-2 | Decreased Appetite, Renal Failure Acute, Rhabdomyolysis
on Jun 25, 2010 Female patient from JAPAN , 88 years of age, weighting 74.96 lb, was diagnosed with hypertension, hyperlipidaemia, cardiac failure, angina pectoris, gastric ulcer and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: decreased appetite, renal failure acute, rhabdomyolysis. Hyzaar dosage: . During the same period patient was treated with MEVALOTIN (View Mevalotin Review and Mevalotin Label ), ATELEC (View Atelec Review and Atelec Label ), LASIX (View Lasix Review and Lasix Label ), SIGMART (View Sigmart Review and Sigmart Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ADALAT (View Adalat Review and Adalat Label ), FRANDOL TAPE S (View Frandol Tape S Review and Frandol Tape S Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6817822-X | Ventricular Extrasystoles
on Jun 24, 2010 Female patient from JAPAN , 82 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular extrasystoles. Hyzaar dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CYCLOSERINE (View Cycloserine Review and Cycloserine Label ), JUVELA (View Juvela Review and Juvela Label ). Patient was hospitalized.

6815384-4 | Blood Creatinine Increased, Blood Uric Acid Increased, Protein Urine Present
Patient was taking Hyzaar (View Usage). Patient had the following side effects: blood creatinine increased, blood uric acid increased, protein urine present on Jun 16, 2010 from JAPAN Additional patient health information: Female patient , 79 years of age, was diagnosed with hypertension and. Hyzaar dosage: 1 Tab/daily, Po. During the same period patient was treated with ALSIODOL (View Alsiodol Review and Alsiodol Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), NORVASC (View Norvasc Review and Norvasc Label ), PEPCID (View Pepcid Review and Pepcid Label ).

6811328-X | Balance Disorder, Hyponatraemia, Nystagmus
Adverse event was reported on Jun 24, 2010 by a Male patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: FRANCE , 55 years of age, After Hyzaar was administered, patient had the following side effects: balance disorder, hyponatraemia, nystagmus. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), PERICIAZINE (View Periciazine Review and Periciazine Label ). Patient was hospitalized.

6806201-7 | Dry Mouth, Dry Throat, Logorrhoea, Product Substitution Issue, Salivary Gland Disorder, Swelling Face
on Jun 24, 2010 Male patient from UNITED STATES , 74 years of age, was diagnosed with hypertension, fluid retention and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, dry throat, logorrhoea, product substitution issue, salivary gland disorder (What is salivary gland disorder?), swelling face. Hyzaar dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), CRESTOR (View Crestor Review and Crestor Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6806195-4 | Aphonia
on Jun 28, 2010 Female patient from ITALY , 45 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: aphonia. Hyzaar dosage: .

6803558-8 | Hypokalaemia, Hyponatraemia
Patient was taking Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: hypokalaemia, hyponatraemia on Jun 23, 2010 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with hypertension, hiatus hernia, major depression, osteoporosis (What is osteoporosis?) and. Hyzaar dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), LASIX (View Lasix Review and Lasix Label ), STABLON (View Stablon Review and Stablon Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), BONIVA (View Boniva Review and Boniva Label ), NORMACOL (STERCULIA) (View Normacol (sterculia) Review and Normacol (sterculia) Label ), CARBOSYMAG (View Carbosymag Review and Carbosymag Label ), SPASFON (View Spasfon Review and Spasfon Label ). Patient was hospitalized.

6803547-3 | Pancytopenia
Adverse event was reported on Jun 23, 2010 by a Male patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension, neuropathy peripheral and. Location: JAPAN , 58 years of age, weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: pancytopenia. During the same period patient was treated with METHYCOOL (View Methycool Review and Methycool Label ).

6801622-0 | Blood Pressure Increased, Headache, Vertigo
on Jun 22, 2010 Male patient from UNITED STATES , 51 years of age, was treated with Hyzaar (View Usage). Patient had the following side effects: blood pressure increased, headache (What is headache?), vertigo. Hyzaar dosage: . Patient was hospitalized.

6801618-9 | Balance Disorder, Hyponatraemia, Nystagmus
on Jun 24, 2010 Male patient from FRANCE , 55 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: balance disorder, hyponatraemia, nystagmus. Hyzaar dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), PERICIAZINE (View Periciazine Review and Periciazine Label ). Patient was hospitalized.

6800297-4 | Gastric Cancer
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: gastric cancer on Jun 08, 2010 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with hypertension and. Hyzaar dosage: 1 Dose/daily/ Po. During the same period patient was treated with ALTAT (View Altat Review and Altat Label ), GASLON N (View Gaslon N Review and Gaslon N Label ), MARZULENE S (View Marzulene-s Review and Marzulene-s Label ), MEVAN (View Mevan Review and Mevan Label ), ULCERIMIN (View Ulcerimin Review and Ulcerimin Label ).

6799776-8 | Blood Creatinine Increased, Blood Uric Acid Increased
Adverse event was reported on Jun 03, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: 1 Tab/daily, Po) was diagnosed with hypertension and. Location: JAPAN , 79 years of age, Patient had the following side effects: blood creatinine increased, blood uric acid increased. During the same period patient was treated with ALSIDOL (View Alsidol Review and Alsidol Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), NORVASC (View Norvasc Review and Norvasc Label ), PEPCID (View Pepcid Review and Pepcid Label ).

6796266-3 | Aphonia
on Jun 24, 2010 Female patient from ITALY , 45 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: aphonia. Hyzaar dosage: .

6795642-2 | Abdominal Pain, C-reactive Protein Increased, Colonic Polyp, Diarrhoea, Gastric Ulcer, Pyrexia, White Blood Cell Count Decreased, White Blood Cell Count Increased
on Jun 15, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with hypertension, prophylaxis and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), c-reactive protein increased, colonic polyp (What is colonic polyp?), diarrhoea, gastric ulcer, pyrexia, white blood cell count decreased, white blood cell count increased. Hyzaar dosage: . During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), DIOVAN (View Diovan Review and Diovan Label ), MINIPRESS (View Minipress Review and Minipress Label ), CALBLOCK (View Calblock Review and Calblock Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6790980-1 | Cardiac Failure, Hyperkalaemia, Renal Failure, Sinus Arrest
Patient was taking Hyzaar (View Usage). Patient had the following side effects: cardiac failure, hyperkalaemia, renal failure, sinus arrest on Jun 16, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with hypertension, cardiac failure, hyperuricaemia, atrial fibrillation (What is atrial fibrillation?) and. Hyzaar dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ALOSITOL (View Alositol Review and Alositol Label ), DIART (View Diart Review and Diart Label ), ARTIST (View Artist Review and Artist Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ). Patient was hospitalized.